Preclinical evaluation of a novel allosteric IL-1R inhibitor (rytvela) for the prevention of perinatal inflammation-induced fetal injury

  • Keelan, Jeffrey (Chief Investigator)
  • Kemp, Matthew (Chief Investigator)
  • Olson, Dave (Chief Investigator)
  • Ellery, Stacey (Chief Investigator)
  • Robertson, Sarah (Chief Investigator)
StatusActive
Effective start/end date1/01/1831/12/21

Funding

  • National Health & Medical Research Council NHMRC